Arrhythmogenic Substrate of Ventricular Arrhythmias at the AMC. Introduction: Catheter ablation of ventricular arrhythmia (VA) at the fibrous aortic mitral continuity (AMC) has been described, yet the nature of the arrhythmogenic substrate remains unknown.
Introduction
The aortic mitral continuity (AMC) is a fibrous structure embedded between the aortic and mitral annuli. Although successful ablations of arrhythmias at the AMC have been reported in the literature, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] knowledge of the clinical, electrocardiographic (ECG), and electrophysiological characteristics of idiopathic ventricular arrhythmias (VAs) arising from this region remains limited. Furthermore, being a fibrous structure, the exact nature of the arrhythmogenic substrate remains unclear. 4, [13] [14] [15] [16] [17] To improve our understanding of this relatively uncommon arrhythmia, we retrospectively reviewed and described the clinical, ECG, and electrophysiological characteristics of idiopathic VAs successfully ablated at the AMC in our institution.
Methods

Patients
This study was approved by the Institutional Review Board of Mayo Clinic, Rochester, MN. Five hundred and twenty-eight patients who underwent ablation of idiopathic VA at Mayo Clinic from 2002 to 2012 were retrospectively reviewed. All patients provided informed consent before their procedure. Twenty-one patients with definitive ablation at the AMC, as confirmed by fluoroscopy and intracardiac echocardiography as stated in the procedural reports, were identified. All patients had either spontaneously present or inducible VAs, which allowed detailed mapping.
Electrophysiology Study and Ablation
Antiarrhythmic drugs were withheld for at least 5 halflives, and amiodarone was withheld for at least 2 weeks prior to the procedure. All procedures were performed under conscious sedation with propofol and fentanyl. Multipolar catheters were inserted percutaneously via the right internal jugular and the common femoral veins and were positioned in the right atrium, right ventricle, coronary sinus, and the His bundle region. Bipolar electrograms (EGMs) were filtered with a bandpass of 30-500 Hz and displayed on a digital recording system (Prucka Engineering, Inc., Houston, TX, USA). VAs were induced by atrial or ventricular burst pacing or programmed stimulation as appropriate. Isoproterenol or epinephrine infusion was given when needed. The mechanisms of arrhythmias were defined based on the methods of induction and response to pacing maneuvers. [18] [19] [20] [21] [22] [23] [24] [25] [26] A 7.5-Fr, 3.5-mm, open-or nonirrigated tip catheter was advanced to the left ventricle via the retrograde aortic approach or through transseptal puncture to map and ablate the VAs. Electroanatomical mapping was performed by means of a three-dimensional mapping system (CARTO, Biosense Webster, Inc., Diamond Bar, CA, USA). During ablation, the earliest local EGMs or prepotentials (PPs) were targeted for focal VAs, 26 and the critical isthmuses were targeted for reentrant VAs. [25] [26] [27] Radiofrequency energy was delivered at each site for 60-120 seconds with the power output capped at 25-40 W. Catheter position was confirmed by fluoroscopy and intracardiac echocardiography. Acute success was defined as noninducibility by pacing maneuvers or infusion of adrenergic agents at the end of the procedure.
Electrocardiography
VAs targeted during procedures were reviewed offline with our digital recording system. Twelve-lead ECGs were interpreted at a sweep speed of 100 mm/s and amplitude of 10 mm/mV. All ECG analyses were performed according to standard criteria by a single cardiologist blinded to the procedural findings.
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Intracardiac Electrograms
Intracardiac EGMs were reviewed on our digital recording system. The V-H interval was defined as the shortest measurable interval from the onset of surface QRS to the His deflection during VA. Local ventricular EGM (VEGM) to QRS interval was measured from the point of maximal deflection (dV/dt) of the bipolar EGM to the onset of the surface QRS. 31 PP was defined as a discrete sharp deflection ahead of and separated from the VEGM by an isoelectric segment of more than 5 milliseconds. 32, 33 When the PP was identified, PP-QRS and PP-VEGM intervals were also assessed.
Statistical Analysis
Continuous variables were reported as mean ± standard deviation. Categorical variables were presented in frequency tables. Statistical comparisons were performed using a 2-tailed Student's t-test or Wilcoxon rank sum test for continuous variables, and Pearson chi-square test or Fisher's exact test for categorical variables, as appropriate. Relationships between the V-H interval and QRS duration were calculated using a linear regression model. P values of <0.05 were considered statistically significant. All analyses were performed using SPSS software (version 21.0, SPSS, Inc., Chicago, IL, USA).
Results
Clinical Characteristics
Twenty-one patients who had VAs successfully ablated at the AMC were included in this study. The mean age of the patients was 53.2 ± 13.4 years, with 10 (47.6%) of them male. Seven (33.3%) patients had a left ventricular ejection fraction (LVEF) of ࣘ50% before ablation. The most common presentation was symptomatic PVCs (n = 16, 76.2%). Other presentations included heart failure (n = 2, 9.5%), symptomatic ventricular tachycardia (VT, n = 1, 4.8%), and PVC-triggered ventricular fibrillation (n = 3, 14.3%). Prior to ablation, Holter recordings and exercise testing documented PVCs in all (100%), nonsustained VT in 9 (42.9%), and sustained VT in 2 (9.5%) patients. At a mean follow-up duration of 12.7 ± 12.8 months, PVC burden was significantly reduced from 23.4 ± 13.1% to 2.2 ± 3.4% (P < 0.001, Table 1 ). All symptoms except syncope improved at follow-up (all P < 0.05, Table 1 ). Three patients who had initial left ventricular dysfunction demonstrated improvement of LVEF to >50% after ablation.
Prepotentials
PPs were found at the successful ablation site in 13 (61.9%) patients (Fig. 1A) . The mean PP-VEGM and the PP-QRS intervals during VAs were 65.7 ± 34.1 milliseconds and 73.7 ± 23.6 milliseconds, respectively. PPs were seen ahead of VEGMs during sinus rhythm in 7 (53.8%) patients. Patients with PPs had a significantly higher PVC burden before ablation than those without PPs (26.1 ± 10.9% vs. 14.9 ± 10.1%, P = 0.03, Table 2 ). Nevertheless, there was no significant difference in patients' demographics, clinical presentations, types of VAs, and echocardiographic findings between those with and without PPs (all P > 0.05, Table 2 ). Multiple VA morphologies were found in 4 patients with PPs but none in those without PP, although the difference did not reach statistical significance (P > 0.05, Table 2 ).
Electrocardiographic Characteristics
ECG characteristics of VAs with and without PPs are presented in Table 3 . A total of 25 VAs were analyzed. The mean QRS duration of VAs was 145.2 ± 16.9 milliseconds in those with PPs and 151.3 ± 21.3 milliseconds in those without PP (P = 0.45). Tall R waves were observed over Table 3 ), while RSR' in V1, deep S wave at V2, and precordial transition demonstrating a rebound pattern 2 was found in another VA without PP (case 11, Table 3 ), although these differences did not reach statistical significance.
Electrophysiological Characteristics
VAs were induced by atrial or ventricular burst pacing in 8 out of 21 patients and infusion of adrenergic agents in 9 out of 17 patients, while none were induced by programmed electrical stimulation. Among the 13 patients with PPs, the earliest VEGMs were located at the AMC in 9 (69.2%), at the junction between the great cardiac vein and the anterior interventricular vein (GCV-AIVV) in 3 (23.1%), and near the left coronary artery in 1 (7.7%). In 2 patients who had the earliest VEGM found at the GCV-AIVV, ablation failed to eliminate the VAs, and thus the electrophysiologists re-mapped the entire region and found the PPs consistently preceding the VAs at the AMC. Ablation of the PPs then successfully eliminated the VAs. For the other 2 patients, the electrophysiologist found the PPs at the AMC during initial mapping and elected to target the PPs instead of the sites of the earliest VEGM. Among the 8 patients without PP, the earliest VEGMs were found at the AMC in 6 (75%) and GCV-AIVV in 2 (25%). Ablations were attempted at the GCV-AIVV in both cases. However, due to failure of power delivery, the electrophysiologists elected to ablate endocardially at the AMC, which successfully eliminated the VAs.
The mean VEGM-QRS duration at the successful ablation sites at the AMC was significantly shorter (9.0 ± 28.5 milliseconds vs. 33.1 ± 8.8 milliseconds, P = 0.03), and the pace map scores were significantly lower (8.7 ± 1.6 vs. 11.4 ± 0.8, P = 0.001) in those with than without PPs ( Table 2) . Ablations were associated with monomorphic VT in 8 (61.5%) patients with PPs and 3 (37.5%) without PP (P = 1.0), and none of them had polymorphic VT or ventricular fibrillation during the procedure. His signal was clearly seen during VAs in 7 patients with PPs and 4 without PPs. VAs with PPs demonstrated a trend towards a shorter V-H interval as compared to those without PPs (32.1 ± 38.6 milliseconds vs. 76.3 ± 11.1 milliseconds, P = 0.06, Table 2 , Fig. 1B) . A strong and positive correlation existed between the V-H interval and QRS duration of VAs with PPs (B = 2.11, R 2 = 0.97, t = 13.7, P < 0.001, Fig. 2 ), but not in those without PP.
Discussion
Of the 21 patients who had successful ablation of VAs at the AMC, PPs were found in 13 (61.9%) of them. Patients who had PPs had a higher PVC burden, and they tended to have multiple VA morphologies and shorter V-H intervals. The VEGM-QRS intervals at the successful ablation sites were significantly shorter, and the pace map scores were significantly lower in those with PPs as compared to those without PPs. In addition, a strong and positive correlation existed between the V-H interval and QRS duration among those with PPs. In the remaining 8 cases no PPs were identified at the sites of successful ablation.
Prepotentials
PP was defined as a discrete sharp deflection that preceded and was separated from the VEGM by an isoelectric segment. 31, 33 A previous study in 10 patients who had VAs ablated at the AMC by Chen et al. found similar PPs in 4 of them, although the exact mechanism was not clarified. 2 In this study, we demonstrated a strongly positive association between the V-H interval and the QRS duration during VA, which suggested that these PPs were likely associated with involvement and activation of conduction tissue.
As the His-Purkinje system is a branching structure, 34 the anterograde wavefront of VA arising from the proximal conduction system simultaneously activates multiple portions of the ventricular myocardium, leading to a narrow QRS complex, while the retrograde wavefront rapidly reaches the His bundle, giving rise to a short V-H interval. On the contrary, the anterograde wavefront of VA arising from the distal conduction system activates only a limited region of the left ventricle, leading to a wide QRS complex, while it takes longer for the retrograde wavefront to activate the His bundle, giving rise to a long V-H interval. Although similar relationship can also be found with VAs originating from ventricular muscle cells at the Purkinje-myocardial interface, wherein the passively involved conduction system gives rise to the PPs, this is less likely given that previous anatomical studies have failed to find any myocardium in this region.
Electrocardiographic Characteristics
Previous studies on the ECG characteristics of VAs originating from the AMC have yielded inconsistent results. 2, 3, 6, 7, 12 Chen et al. attempted to explain these differences by dividing the AMC into anterior and mid portions. 2 They have shown that all VAs originating from the anterior AMC have a left bundle branch block pattern and precordial transition ࣘ V2, whereas VAs originating from the mid AMC have a right bundle branch block pattern, and rebound transition pattern is commonly seen. 2 However, this does not explain the variable appearance of Q waves in V1 and S waves in some of the precordial leads. 2 In our study, we found that the QRS morphologies appeared to be more variable in VAs associated with PPs than those without PPs. These included the presence of left bundle branch morphology, Q waves in V1, deep S waves in V2, and precordial transition >V1. Furthermore, multiple QRS morphologies arising from the same arrhythmic focus were also seen in those VAs associated with PPs. Although the exact mechanism remains unknown, one possible explanation for the variable QRS morphologies found in this study, as well as the previous ones, could be due to variable involvement of and exit from the His-Purkinje system, either actively or passively.
Possible Arrhythmogenic Substrate
Although successful ablation of arrhythmias at the AMC has been described, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] the exact nature of the arrhythmogenic substrate remains unknown. 4, [13] [14] [15] [16] [17] While no myocardium has been found in this region, animal studies have shown that cells with electrophysiological properties similar to that of the atrioventricular (AV) junctional cells are present near the mitral annulus. 35, 36 During embryonic development, specialized conduction tissue encircles both AV orifices, including the fibrous AMC. 4, 37 This ring of conduction tissue matures into the left and right bundle branches, as well as a third septal branch that normally regresses at the later stage. 16, 34 Studies have suggested that AV junctional tissue that fails to regress can become arrhythmogenic later in life. 4, 16, 36, 38 Furthermore, depending on their connection with the atrium, ventricle, and various parts of the normal conduction system including the AV node, bundle branches, and fascicles, arrhythmias associated with remnant conduction tissues at the AMC may have different ECG and electrophysiological manifestations. 4, 16, 35, 36 To our knowledge, no anatomical study has demonstrated the presence of ventricular muscle in the AMC. While our findings do not refute this possibility, it is plausible that isolated cells from the degenerated conduction system give rise to these VAs. Another possibility is that the AMC only acts as a vantage point for ablation of epicardial arrhythmic foci. Unfortunately, none of these possibilities can be easily proven in human studies.
Limitations
This study had a small sample size, and thus statistical significance was not reached in most of the electrocardiographic parameters despite an apparent difference in prevalence. In addition, induction and pacing maneuvers were not performed systematically in all patients due to technical difficulties or the individual electrophysiologists' preferences. This led to difficulty in delineating the mechanism of VA in 3 patients. Furthermore, the V-H interval could not be discerned in 10 patients without PP, possibly due to the close proximity of the His signal and the VEGM. Nevertheless, the strong and positive correlation between the V-H intervals and the QRS duration in those with PP remained. Lastly, there are several potential reasons for a change in the local ventricular electrogram, which include differential movement of the mapping catheter relevant to the fibrous AMC, different wavefront of activation of the ventricular myocardium during the PVC versus conducted sinus beats, or loss of catheter contact. Multiple mechanisms of arrhythmia may have been operative in these patients, including peri-AMC myocardium or Purkinje origin that could not be distinguished from true AMC origin despite real-time intracardiac ultrasound echocardiographic evaluation. Despite these possibilities, we have shown that the site of ablation was verified by intracardiac echo and ablation eliminated VA at this site, making these potential alternative explanations unlikely.
Conclusion
We present the clinical, ECG, and electrophysiological characteristics of a series of patients who had VAs successfully ablated at the AMC. In particular, PPs were targeted for successful ablation in over half of the patients. When ablation at sites with the earliest VEGM and best pace map score, which represents the exit site, does not eliminate the arrhythmia, detailed mapping to identify and target the earliest PP may improve procedural success at this location.
